Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
Ali Hassoun, Elizabeth Thottacherry, Justin Muklewicz, Qurrat-ul-ain Aziz, Jonathan Edwards
Topics & Concepts
TocilizumabCytokine release syndromeCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakMedicineCytokineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Interleukin 6ImmunologyVirologyInternal medicineRheumatoid arthritisDiseaseOutbreakInfectious disease (medical specialty)Long-Term Effects of COVID-19Autoimmune and Inflammatory Disorders ResearchCOVID-19 Clinical Research Studies